PLoS ONE (Jan 2018)

Impact of a multidisciplinary team for the management of thrombotic microangiopathy.

  • Miguel G Uriol Rivera,
  • Sheila Cabello Pelegrin,
  • Carmen Ballester Ruiz,
  • Bernardo López Andrade,
  • Javier Lumbreras,
  • Aina Obrador Mulet,
  • Albert Perez Montaña,
  • Mireia Ferreruela Serlavos,
  • José Ignacio Ayestarán Rota,
  • Joana Ferrer Balaguer,
  • Olga Delgado Sanchez,
  • Lucio Pallares Ferreres,
  • Antonio Mas Bonet,
  • María Jose Picado Valles,
  • Rosa María Ruíz de Gopegui Valero

DOI
https://doi.org/10.1371/journal.pone.0206558
Journal volume & issue
Vol. 13, no. 11
p. e0206558

Abstract

Read online

BACKGROUND:Thrombotic microangiopathy (TMA) is an important complication associated with several diseases that are rare and life-threatening. TMA is common to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP is defined by a severe deficiency of ADAMTS13, and early treatment is associated with good prognosis. The diagnosis of HUS can be difficult due to the potential multiple etiologies, and the best treatment option in most cases is not well-established yet. The implementation of a multidisciplinary team (MDT) could decrease the time to diagnosis and treatment for HUS and may improve the outcomes of these patients. OBJECTIVE:To determine the impact of MDT on morbidity and mortality [death or chronic renal replacement therapy (CRRT) requirements], incidence and response time [(RT) defined as the period between hospital admission and the first day of direct therapy administration], length of stay at an intensive care unit (ICU-LOS) and total hospitalization (T-LOS) were also assessed. METHODS:We compared a pre-MDT implementation period (from January/2008 to May/2016) versus post-MDT period (from May/2016 to December/2016). The screening TMA diagnosis was made according the following criteria: hemolytic anemia, thrombocytopenia and acute renal damage and without ADAMTS13 deficiency. An online chat was implemented to provide instant medical information. RESULTS:Twenty-eight patients were included. The incidence changed from 2.3 cases/pre-MDT: (all cases: n = 18) to 10 cases/year post-MDT (all cases: n = 10). Two patients died in pre-MDT and post- MDT (11% versus 20%, P = 0.60). From pre-MDT, the number of patients who required CRRT by post-MDT decreased from 7 (39%) to 0, P = 0.03. Similarly, RT, ICU-LOS and T-LOS [median(p25-p75)] decreased from 10 (2-12) days to 0.5 (0-1.5) days, P = 0.04, from 16 (9-30) days to 10 (4-13) days, P = 0.01 and from 33 (22-53) days to 16 (12-32) days, P < 0.01, respectively. CONCLUSION:MDT implementation was associated with a greater number of patients who meet TMA criteria. A decrease in the RT and T-LOS periods were observed and associated with better outcomes in these patients.